| David Jason Phillips, MD | |
|
515 W Mayfield Rd Ste 200, Arlington, TX 76014-4596 | |
| (817) 465-7868 | |
| Not Available |
| Full Name | David Jason Phillips |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 515 W Mayfield Rd Ste 200, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922201094 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | N2731 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Mother Frances Hospital | Tyler, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christus Trinity Clinic | 3072426741 | 1227 |
News Archive
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians.
A new study at the University of Leicester is examining a sequence of DNA- known as telomeres - that varies in length between individual.
In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, MD, PhD, discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought.
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
› Verified 9 days ago
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians.
A new study at the University of Leicester is examining a sequence of DNA- known as telomeres - that varies in length between individual.
In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, MD, PhD, discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought.
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
› Verified 9 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians.
A new study at the University of Leicester is examining a sequence of DNA- known as telomeres - that varies in length between individual.
In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, MD, PhD, discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought.
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Jason Phillips, MD 700 Olympic Plaza Cir, Ste 602, Tyler, TX 75701-1954 Ph: (903) 593-2468 | David Jason Phillips, MD 515 W Mayfield Rd Ste 200, Arlington, TX 76014-4596 Ph: (817) 465-7868 |
News Archive
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians.
A new study at the University of Leicester is examining a sequence of DNA- known as telomeres - that varies in length between individual.
In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, MD, PhD, discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought.
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
› Verified 9 days ago
Jessica Brown, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1001 N Waldrop Dr Ste 505, Arlington, TX 76012 Phone: 817-412-7048 | |
Donald Jay Davis, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1550 Jones Drive, Arlington, TX 76013 Phone: 817-275-6482 Fax: 817-275-6956 | |
Janis R Cornwell, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 515 W Mayfield Rd, Ste 200, Arlington, TX 76014 Phone: 817-468-4689 Fax: 817-465-7872 | |
Dr. Abel Moron, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 906 W Randol Mill Rd Ste 200, Arlington, TX 76012 Phone: 817-664-9600 Fax: 817-261-5837 | |
Stephanie Ann Pickel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 505 Omega Dr, Arlington, TX 76014 Phone: 817-468-3255 Fax: 817-468-7823 | |
Maya Alex Kuriakose, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1001 N. Waldrop, Suite 505, Arlington, TX 76012 Phone: 817-591-2715 | |
Dr. Mahendra O Thakrar, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2608 Matlock Rd, Arlington, TX 76015 Phone: 817-861-4499 Fax: 817-861-8411 |